NAMs

Redmond, Washington, U.S., September 22, 2026 SystImmune, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...

SAN ANTONIO, Texas, April 20, 2026 Texas Biomedical Research Institute (Texas Biomed), in collaboration with the Southwest National Primate...